% Expired Patents = 75.0

Forward Citations = 7

Loading Chart...

6 inventors (with patents filed for the assignee):

Daniel S Sem (3 out of 11 patents)

Maurizio Pellecchia (3 out of 24 patents)

Anna Maria Tempczyk-Russell (2 out of 8 patents)

4. Mark R Hansen (1 out of 5 patents)

5. Hugo O Villar (1 out of 21 patents)

6. Richard Kho (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 7252931 - NMR-solve method for rapid identification of bi-ligand drug candidates (2007-08-07),

2. 6979531 - SEA-TROSY and related methods (2005-12-27),

3. 6797460 - NMR-solve method for rapid identification of bi-ligand drug candidates (2004-09-28),

4. 6792355 - Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences (2004-09-14),

Company Overview

Triad Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for various diseases. With a team of experienced researchers and healthcare professionals, Triad Therapeutics is dedicated to advancing novel treatments that improve patient outcomes and quality of life. Visit our website to learn more about our pipeline of promising drug candidates and ongoing research efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1,006 in San Diego, CA

#14,041 in California

#60,597 in US

San Diego, CA, United States of America

Triad Therapeutics, Inc.

Forward Citations = 7

6 inventors:

Daniel S Sem (3 out of 11 patents)

Maurizio Pellecchia (3 out of 24 patents)

Anna Maria Tempczyk-Russell (2 out of 8 patents)

4. Mark R Hansen (1 out of 5 patents)

5. Hugo O Villar (1 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Triad Therapeutics, Inc.. Retrieved from https://idiyas.com/company/triad-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]